Pure Extracts Technologies (CNSX:PULL) - Stock Price, News & Analysis

PULL Stock Overview

Engages in the extraction and processing of cannabis and hemp to produce oils and various derivative products in Canada. More details

PULL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Revenue grew by 157.2% over the past year

Risk Analysis

Does not have a meaningful market cap (CA$1M)

Shares are highly illiquid

Negative shareholders equity

Latest financial reports are more than a year old

+ 1 more risk

Pure Extracts Technologies Corp. Competitors

RAMM Pharma

CNSX:RAMM

CA$2.4m

Lophos Holdings

CNSX:MESC

CA$858.6k

SugarBud Craft Growers

TSXV:SUGR.H

CA$718.6k

TILT Holdings

NEOE:TILT

CA$2.0m

Price History & Performance

Summary of all time highs, changes and price drops for Pure Extracts Technologies
Historical stock prices
Current Share Price	CA$0
52 Week High	CA$0
52 Week Low	CA$0
Beta	2.07
11 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	n/a

Recent updates

Shareholder Returns

	PULL	CA Pharmaceuticals	CA Market
7D	n/a	0.03%	1.3%
1Y	n/a	-20.8%	23.7%

Return vs Industry: Insufficient data to determine how PULL performed against the Canadian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how PULL performed against the Canadian Market.

Price Volatility

Is PULL's price volatile compared to industry and market?
PULL volatility
PULL Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.6%
Market Average Movement	8.4%
10% most volatile stocks in CA Market	17.5%
10% least volatile stocks in CA Market	3.0%

Stable Share Price: PULL has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine PULL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Ben Nikolaevsky	pureextractscorp.com

Pure Extracts Technologies Corp. engages in the extraction and processing of cannabis and hemp to produce oils and various derivative products in Canada. The company offers THC and CBD based extracted oils. It also engages in the development and commercialization of functional wellness products and psychedelic medical products.

Pure Extracts Technologies Corp. Fundamentals Summary

How do Pure Extracts Technologies's earnings and revenue compare to its market cap?
PULL fundamental statistics
Market cap	CA$1.17m
Earnings (TTM)	-CA$4.00m
Revenue (TTM)	CA$2.44m

0.0x

P/S Ratio

0.0x

P/E Ratio

Is PULL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PULL income statement (TTM)
Revenue	CA$2.44m
Cost of Revenue	CA$2.68m
Gross Profit	-CA$244.59k
Other Expenses	CA$3.75m
Earnings	-CA$4.00m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.034
Gross Margin	-10.03%
Net Profit Margin	-163.85%
Debt/Equity Ratio	-568.7%

How did PULL perform over the long term?

See historical performance and comparison

PULL Stock Overview

Rewards

Risk Analysis

Pure Extracts Technologies Corp. Competitors

CNSX:RAMM

CA$2.4m

CNSX:MESC

CA$858.6k

TSXV:SUGR.H

CA$718.6k

NEOE:TILT

CA$2.0m

Price History & Performance

Recent News & Updates

Pure Extracts Technologies Corp. Announces Board and Secretary Changes

Pure Extracts Technologies Corp. Announces Resignation of Yana Popova as Chief Financial Officer

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.01 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.014 loss in 1Q 2022)

Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to List Pure Pulls Vapes and Pure Chews Edibles

Less than half of directors are independent

Recent updates

Pure Extracts Technologies Corp. Announces Board and Secretary Changes

Pure Extracts Technologies Corp. Announces Resignation of Yana Popova as Chief Financial Officer

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.01 loss in 2Q 2022)

First quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.014 loss in 1Q 2022)

Pure Extracts Receives Approval from Manitoba Liquor & Lotteries to List Pure Pulls Vapes and Pure Chews Edibles

Less than half of directors are independent

Less than half of directors are independent

Pure Extracts Technologies Corp. announced that it has received CAD 0.445275 million in funding

Founder recently sold CA$51k worth of stock

Pure Extracts Commences Production of 1 Gram FSO Vape Cartridges in Preparation for Retail Distribution and Revenue

CEO & Director recently sold CA$63k worth of stock

Pure Extracts Technologies Corp. Sells First Shipment of Cannabis Oil Extracts to German Pharma Company

Pure Extracts Technologies Corp. and ShroomBloom Labs Sign Psychedelic Mushroom Supply Letter of Intent

Pure Extracts Technologies Corp. Submits Dealer’s Licence Application to Health Canada

Pure Extracts Submits Application to Health Canada for Sales License

Pure Extracts Technologies Corp. Submits Multiple SKUs to Health Canada for Approval

Pure Extracts Technologies Corp. and Canada House Wellness Group Sign Agreement to Distribute Concentrate Products Through Existing Provincial Distribution Channels

New 90-day high: CA$0.81

Pure Extracts Agrees to Licensing Deal with Taste-T, LLC for Fireball Cannabis Gummies

Pure Extracts Technologies Corp. Announces its First Commercial Sale of CBD Oil on the Wholesale Market

Pure Extracts Enters into Biomass Purchase Agreements to Support Oil Extract Production

Pure Extracts Technologies Corp. announced that it has received CAD 8.534633 million in funding

Pure Extracts Technologies Corp. Delineates Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Technologies Corp. Commences Build-Out of Facility in Preparation for Mushroom Extraction and Dealer's Licence

Pure Extracts Applauds Health Canada SAP for Psilocybin-Assisted Psychotherapy Inclusion

Pure Extracts Collaborates with Dr. Alexander Macgregor on Cannabis and Mushroom Formulations

Pure Extracts Technologies Common Shares to Be Deleted from Other OTC

Pure Extracts Technologies Corp. Advances Plans for the Processing of Functional Mushroom Formulations

Shareholder Returns

Price Volatility

About the Company

Pure Extracts Technologies Corp. Fundamentals Summary

0.0x

0.0x

Earnings & Revenue